This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 10 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2013-2023.
Location History:
- Jambu Savari Dinne, IN (2013 - 2016)
- Karnataka, IN (2019 - 2021)
- Bengaluru, IN (2015 - 2023)
Company Filing History:
Years Active: 2013-2023
Title: Prashantha Gunaga: Innovator in Pharmaceutical Chemistry
Introduction
Prashantha Gunaga is a prominent inventor based in Bengaluru, India, known for his significant contributions in the field of pharmaceutical chemistry. With a total of 14 patents to his name, Gunaga has made noteworthy advancements in the development of compounds that address critical health issues, particularly in cardiovascular diseases and ion channel disorders.
Latest Patents
One of his latest patents focuses on "Substituted nitrogen containing compounds." This patent discloses compounds of a specific formula, where various components are defined, showcasing their potential as inhibitors of ROMK (Renal Outer Medullary Potassium channel). These compounds are particularly useful in treating cardiovascular diseases. Another recent patent involves "Quinazolines as potassium ion channel inhibitors," which delineates a compound formula aimed at inhibiting potassium channel function. This invention is aimed at the treatment and prevention of arrhythmia and other disorders mediated by ion channel function, highlighting Gunaga’s role in tackling significant medical challenges.
Career Highlights
Prashantha Gunaga is affiliated with Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. His tenure at this organization has allowed him to leverage his expertise in the synthesis and application of innovative chemical compounds. His work directly contributes to the advancement of therapeutic solutions, making a considerable impact on the pharmaceutical industry.
Collaborations
Throughout his career, Gunaga has collaborated with notable coworkers, including John E. Lloyd and Heather J. Finlay. These collaborations have been essential in fostering innovative research and development in the realm of pharmaceutical sciences, allowing for a blend of ideas and expertise that enhance the efficacy of their inventions.
Conclusion
Prashantha Gunaga's innovation journey is characterized by a commitment to creating solutions for critical health problems through his extensive patent portfolio. His ongoing work at Bristol-Myers Squibb reflects a dedication to advancing healthcare, making him a noteworthy inventor in the pharmaceutical chemistry landscape. With a continued focus on impactful inventions, Gunaga is set to play a significant role in improving patient outcomes globally.